ALKBH5 and glioblastoma: Interestingly, despite the cells stimulating different levels of heterogeneity, ALKBH5, as a negative GBM prognostic factor that has previously been identified, did not show any significant differential expression between the GBM monoclonal cells (Figures 1F,G and S2D,E).